These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 6152556)

  • 1. Application of agents active at the alpha 2-adrenoceptor of fat cells to the treatment of obesity--a critical appraisal.
    Curtis-Prior PB; Tan S
    Int J Obes; 1984; 8 Suppl 1():201-13. PubMed ID: 6152556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of the alpha 2/beta-adrenoceptor-coupled adenylate cyclase system and their relationship with adrenergic responsiveness in hamster fat cells from different anatomical sites.
    Dieudonne MN; Pecquery R; Giudicelli Y
    Eur J Biochem; 1992 Apr; 205(2):867-73. PubMed ID: 1349284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostaglandins, alpha-adrenergic receptors and lipolysis in hamster fat cells.
    Tan S; Curtis-Prior PB
    Prostaglandins Leukot Med; 1985 Jan; 17(1):117-23. PubMed ID: 2579405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of androgenic status on the alpha 2/beta-adrenergic control of lipolysis in white fat cells: predominant alpha 2-antilipolytic response in testosterone-treated-castrated hamsters.
    Pecquery R; Leneveu MC; Giudicelli Y
    Endocrinology; 1988 Jun; 122(6):2590-6. PubMed ID: 2453344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of adipose tissue metabolism via adrenergic mechanisms: actions of alpha-adrenoceptor agonists on lipolysis in hamster fat cells.
    Curtis-Prior PB; Tan S
    Int J Obes; 1983; 7(4):299-305. PubMed ID: 6138316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adrenoceptor of the alpha 2-subtype mediating inhibition of the human fat cell adenylate cyclase.
    Kather H; Simon B
    Eur J Clin Invest; 1981 Apr; 11(2 Suppl 1):111-4. PubMed ID: 6112151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipolytic catecholamine resistance linked to alpha 2-adrenoceptor sensitivity--a metabolic predictor of weight loss in obese subjects.
    Hellström L; Rössner S; Hagström-Toft E; Reynisdottir S
    Int J Obes Relat Metab Disord; 1997 Apr; 21(4):314-20. PubMed ID: 9130030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha-2 adrenergic antilipolytic effect in dog fat cells: incidence of obesity and adipose tissue localization.
    Berlan M; Carpene C; Lafontan M; Dang-Tran L
    Horm Metab Res; 1982 May; 14(5):257-60. PubMed ID: 6284627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adipose tissue lipolysis as a metabolic pathway to define pharmacological strategies against obesity and the metabolic syndrome.
    Langin D
    Pharmacol Res; 2006 Jun; 53(6):482-91. PubMed ID: 16644234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha 2-adrenergic inhibition of insulin secretion via interference with cyclic AMP generation in rat pancreatic islets.
    Yamazaki S; Katada T; Ui M
    Mol Pharmacol; 1982 May; 21(3):648-53. PubMed ID: 6125877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Lipid mobilization, physiopathological and pharmacological aspects].
    Berlan M; Barbe P; Stich V; Galitzky J; Bousquet-Mélou A; Lafontan M
    Ann Endocrinol (Paris); 1995; 56(2):97-100. PubMed ID: 7755346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human fat cell alpha-2 adrenoceptors. I. Functional exploration and pharmacological definition with selected alpha-2 agonists and antagonists.
    Galitzky J; Mauriege P; Berlan M; Lafontan M
    J Pharmacol Exp Ther; 1989 May; 249(2):583-91. PubMed ID: 2566681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory alpha-2 adrenoceptors in human adipose tissue.
    Lafontan M; Berlan M
    Int J Obes; 1981; 5(6):651-7. PubMed ID: 6119296
    [No Abstract]   [Full Text] [Related]  

  • 14. Lack of desensitization of alpha-2-mediated inhibition of lipolysis in fat cells after acute and chronic treatment with clonidine.
    Villeneuve A; Carpene C; Berlan M; Lafontan M
    J Pharmacol Exp Ther; 1985 May; 233(2):433-40. PubMed ID: 2987483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological characterization of alpha-2 adrenergic receptor subtype involved in the release of insulin from isolated rat pancreatic islets.
    Niddam R; Angel I; Bidet S; Langer SZ
    J Pharmacol Exp Ther; 1990 Sep; 254(3):883-7. PubMed ID: 1975625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-lipolytic action of prazosin in hamster fat cells.
    Tan S; Curtis-Prior PB
    Pharmacol Res Commun; 1984 May; 16(5):451-9. PubMed ID: 6204344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional involvement of alpha 1- and alpha 2-adrenoceptors in 86Rb efflux from liver slices and lipolysis in guinea-pig isolated adipocytes.
    Maroto R; Moratinos J; Sancho C
    J Auton Pharmacol; 1992 Oct; 12(5):277-90. PubMed ID: 1358889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha 2-adrenoceptor stimulation affects total glucose utilization in isolated islets of Langerhans.
    Laychock SG
    Mol Pharmacol; 1987 Aug; 32(1):241-8. PubMed ID: 2441240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drop in the "atypical" beta-adrenergic response and modification of the beta/alpha 2-adrenoceptor balance in fat cells from aging rabbits.
    Langin D; Portillo M; Dauzats M; Lafontan M
    Endocrinology; 1992 Jan; 130(1):307-15. PubMed ID: 1309335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of dibutyryl cyclic AMP-induced insulin release by alpha-2 adrenergic stimulation.
    Nakaki T; Nakadate T; Yamamoto S; Kato R
    Life Sci; 1983 Jan; 32(3):191-5. PubMed ID: 6130458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.